ResMed stock heads into the open after a 3.3 percent slide
Published on 09/10/2026 at 04:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ResMed stock closed at USD 221.05 on the NYSE on September 9, 2026, down 3.3 percent from the prior close in a session that saw the shares trade between USD 220.45 and USD 226.67. The move came as major US equity benchmarks also lost ground on September 9, 2026, with the Dow Jones Industrial Average falling 0.77 percent, the S&P 500 index slipping 0.48 percent and the Nasdaq Composite index declining 0.64 percent, underscoring a risk-off tone across the market.
September 9, 2026 in numbers
ResMed Inc. (ISIN US7611521078, NYSE: RMD) recorded a close at USD 221.05 on September 9, 2026 on the NYSE, compared with a prior close of USD 228.35, marking a decline of 3.3 percent for the session. Per NYSE data shown by MarketWatch, the shares traded in a day range from USD 220.45 to USD 226.67 on September 9, 2026, while the quoted 52-week range stood between USD 180.27 and USD 284.87, placing the latest close roughly in the lower half of that band.MarketWatch In the same session, the S&P 500 index closed down 0.48 percent at 7,636.46 and the Nasdaq Composite index ended 0.64 percent lower at 26,253.34, indicating that ResMed’s decline slightly exceeded the broader market’s losses.TradingKey
Today’s factors for ResMed
Today, September 10, 2026, ResMed heads into the open without a newly reported company-specific release in the early hours, so traders are likely to focus on the broader backdrop of US monetary policy expectations and healthcare sector sentiment that weighed on equities in the previous session.TradingKey With ResMed’s share price now sitting well below its quoted 52-week high of USD 284.87, the stock is sensitive to shifts in risk appetite ahead of upcoming macroeconomic data and any future health care policy developments that could influence demand for medical devices and respiratory care solutions.
